Article

Thalassemia an update: molecular basis, clinical features and treatment

2018-01-15

Abstract excerpt

Thalassemia are a group of inherited blood disorders caused by the decrease or absence of beta-globin chain synthesis will be determined with decrease in erythrocyte hemoglobin, decreased production of erythrocytes and anemia. More thalassemia is inherited as recessive autosomal. According to this fact that which one of the chains are involved, they invide into two type including alpha and beta thalassemia, which...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bf138c09-5b3b-5306-8745-44d5febe34c1
DOI: 10.22631/ijbmph.2018.56102

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Thalassemia an update: molecular basis, clinical features and treatmentDOI 10.22631/ijbmph.2018.56102Read

Current Perspective of Beta Thalassemia and Its Treatment StrategiesSemantic proximity Read

ThalassemiaSemantic proximity Read

Current status of beta-thalassemia and its treatment strategies.Semantic proximity Read

Pathophysiology and treatment of patients with beta-thalassemia – an updateSemantic proximity Read

Hemoglobinopathies in Iran: An Updated ReviewSemantic proximity Read

Thalassemia, a human blood disorderSemantic proximity Read

Thalassemia and related hemoglobinopathies.Semantic proximity Read

Clinical Classification, Screening and Diagnosis for Thalassemia.Semantic proximity Read

Thalassemias: from gene to therapy.Semantic proximity Read

Alpha-Thalassemia: Diversity of Clinical Phenotypes and Update on the TreatmentSemantic proximity Read

Diagnosis and prevention of thalassemia.Semantic proximity Read

Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical ManagementSemantic proximity Read